Stada expands its European treatment portfolio
Company adds a number of additional brands from Sanofi following initial take overs in 2021
Read More
Tag: European
Sanofi creates European drug ingredients business
When completed, the planned company will allegedly rank as the world’s second largest API company with approximately €1 billion in expected sales by 2022.
Read More
Libtayo bags EU approval for skin cancer
The European Commission has granted conditional marketing authorisation for the drug for patients who are not candidates for curative surgery or curative radiation.
Read More
European approval for Teva’s migraine drug Ajovy
The drug is a pre-filled syringe for the prophylaxis of migraine in adults who have at least four migraine days per month.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
